Literature DB >> 22517775

Urocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying.

Pu-Qing Yuan1, S Vincent Wu, Yvette Taché.   

Abstract

Peripheral activation of corticotropin-releasing factor receptor type 2 (CRF(2)) by urocortin 1, 2, or 3 (Ucns) exerts powerful effects on gastric function; however, little is known about their expression and regulation in the stomach. We investigated the expression of Ucns and CRF(2) isoforms by RT-PCR in the gastric corpus (GC) mucosa and submucosa plus muscle (S+M) or laser captured layers in naive rats, their regulations by lipopolysaccharide (LPS, 100 μg/kg ip) over 24 h, and the effect of the CRF(2) antagonist astresssin(2)-B (100 μg/kg sc) on LPS-induced delayed gastric emptying (GE) 2-h postinjection. Transcripts of Ucns and CRF(2b,) the most common wild-type CRF(2) isoform in the periphery, were expressed in all layers, including myenteric neurons. LPS increased Ucn mRNA levels significantly in both mucosa and S+M, reaching a maximal response at 6 h postinjection and returning to basal levels at 24 h except for Ucn 1 in S+M. By contrast, CRF(2b) mRNA level was significantly decreased in the mucosa and M+S with a nadir at 6 h. In addition, CRF(2a), reportedly only found in the brain, and the novel splice variant CRF(2a-3) were also detected in the GC, antrum, and pylorus. LPS reciprocally regulated these variants with a decrease of CRF(2a) and an increase of CRF(2a-3) in the GC 6 h postinjection. Astressin(2)-B exacerbated LPS-delayed GE (42-73%, P < 0.001). These data indicate that Ucn and CRF(2) isoforms are widely distributed throughout the rat stomach and inversely regulated by immune stress. The CRF(2) signaling system may act to counteract the early gastric motor alterations to endotoxemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517775      PMCID: PMC3404575          DOI: 10.1152/ajpgi.00547.2011

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  70 in total

1.  Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.

Authors:  K E Habib; K P Weld; K C Rice; J Pushkas; M Champoux; S Listwak; E L Webster; A J Atkinson; J Schulkin; C Contoreggi; G P Chrousos; S M McCann; S J Suomi; J D Higley; P W Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Corticotropin releasing factor receptors and their ligand family.

Authors:  M H Perrin; W W Vale
Journal:  Ann N Y Acad Sci       Date:  1999-10-20       Impact factor: 5.691

3.  Regulation of type-2 corticotropin-releasing hormone receptor mRNA in rat heart by glucocorticoids and urocortin.

Authors:  K Asaba; S Makino; M Nishiyama; K Hashimoto
Journal:  J Cardiovasc Pharmacol       Date:  2000-10       Impact factor: 3.105

4.  Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.

Authors:  Christos Tsatsanis; Ariadne Androulidaki; Erini Dermitzaki; Achille Gravanis; Andrew N Margioris
Journal:  J Cell Physiol       Date:  2007-03       Impact factor: 6.384

5.  Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines.

Authors:  K Kageyama; G E Gaudriault; M J Bradbury; W W Vale
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

6.  Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids.

Authors:  K Kageyama; M J Bradbury; L Zhao; A L Blount; W W Vale
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

Review 7.  Anorexia of infection: current prospects.

Authors:  W Langhans
Journal:  Nutrition       Date:  2000-10       Impact factor: 4.008

8.  Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.

Authors:  J C Bittencourt; J Vaughan; C Arias; R A Rissman; W W Vale; P E Sawchenko
Journal:  J Comp Neurol       Date:  1999-12-20       Impact factor: 3.215

9.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.

Authors:  K Van Pett; V Viau; J C Bittencourt; R K Chan; H Y Li; C Arias; G S Prins; M Perrin; W Vale; P E Sawchenko
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

10.  Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats.

Authors:  N Kihara; M Fujimura; I Yamamoto; E Itoh; A Inui; M Fujimiya
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-03       Impact factor: 4.052

View more
  8 in total

1.  Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.

Authors:  Pu-Qing Yuan; S Vincent Wu; Charalabos Pothoulakis; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

Review 2.  Key role of CRF in the skin stress response system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Desmond J Tobin; Theoharis C Theoharides; Jean Rivier
Journal:  Endocr Rev       Date:  2013-08-12       Impact factor: 19.871

3.  Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats.

Authors:  Lixin Wang; Andreas Stengel; Miriam Goebel-Stengel; Almaas Shaikh; Pu-Qing Yuan; Yvette Taché
Journal:  Peptides       Date:  2012-11-23       Impact factor: 3.750

4.  Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.

Authors:  Tsukasa Nozu; Saori Miyagishi; Rintaro Nozu; Kaoru Takakusaki; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2016-04-13       Impact factor: 7.527

Review 5.  CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Neurosci       Date:  2014-03-18       Impact factor: 4.677

6.  Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia.

Authors:  Yvette Taché; Mulugeta Million
Journal:  J Neurogastroenterol Motil       Date:  2015-01-31       Impact factor: 4.924

Review 7.  Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response.

Authors:  Andreas Stengel; Yvette F Taché
Journal:  Front Neurosci       Date:  2017-04-25       Impact factor: 4.677

Review 8.  Gut-Brain Neuroendocrine Signaling Under Conditions of Stress-Focus on Food Intake-Regulatory Mediators.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.